Conexus Wireless Telemetry - PowerPoint PPT Presentation

1 / 8
About This Presentation
Title:

Conexus Wireless Telemetry

Description:

The FCC established MICS in 1999 to provide an 'ultra-low power, mobile radio ... acceleration of ventricular tachycardia, and surgical complications such ... – PowerPoint PPT presentation

Number of Views:928
Avg rating:3.0/5.0
Slides: 9
Provided by: daveh58
Category:

less

Transcript and Presenter's Notes

Title: Conexus Wireless Telemetry


1
Conexus Wireless Telemetry
2
MICS Background
  • In the United States, the Federal Communications
    Commission (FCC) regulates use of the radio
    frequency spectrum, and regulatory rules make a
    number of frequency bands potential candidates
    for use by medical devices.
  • However, ONE frequency band is designated
    specifically for implanted medical devices the
    Medical Implant Communications Service (MICS)
  • The FCC established MICS in 1999 to provide an
    ultra-low power, mobile radio service for
    transmitting data in support of diagnostic or
    therapeutic functions associated with implanted
    medical devices.
  • The MICS frequency band operates from 402 MHz to
    405 MHz. The use of the 402-405 MHz band is
    compatible with international frequency
    allocations, and these frequencies are conducive
    to transmitting radio signals in the human body.

3
Conexus Wireless Telemetry
  • Medtronics Conexus Wireless Telemetry operates
    on the MICS band
  • Medtronic strategically chose MICS for optimum
    operation in clinics and operating rooms
  • Conexus Wireless Telemetry employs several
    unique mechanisms used to avoid radio
    interference, when present including Smart Radio.

4
Smart Radio
  • Selects one of 10 channels within the MICS
    frequency band to establish a telemetry session
    based on the MICS standard Listen Before Talk
    (LBT) frequency-access protocol.
  • Scans all channels in the MICS band for other
    users, or noise, prior to establishing a
    telemetry session. Conexus Telemetry will open a
    session on the least interfered channel.
  • This protocol allows multiple simultaneous
    programming sessions to be collocated without
    interference.

5
Conexus Performance Testing
  • Conexus has been in development / testing for
    nearly 10 years.
  • Medtronic has initiated variety of testing in
    both bench and real world settings.
  • Users can have confidence in the ability to
    conduct all aspects of device interrogation and
    programming within labeled range (2-5M)

6
Potential Clinical Applications
  • Implant
  • Remove programming head from sterile field
  • Follow-up
  • Perform wandless programming / interrogation
  • Potentially eliminate surface electrodes with
    Leadless ECG
  • Remote Monitoring
  • Wirelessly / Automatically transmit device data
    to peripheral monitors

7
  • Brief Statement Medtronic ICDs and CRT-ICDs
  • Indications
  • Medtronic Implantable Cardioverter
    Defibrillators (ICDs) are indicated for
    ventricular antitachycardia pacing and
    ventricular defibrillation for automated
    treatment of life-threatening ventricular
    arrhythmias.
  • Medtronic Cardiac Resynchronization Therapy
    (CRT) ICDs are indicated for ventricular
    antitachycardia pacing and ventricular
    defibrillation for automated treatment of
    life-threatening ventricular arrhythmias and for
    the reduction of the symptoms of moderate to
    severe heart failure (NYHA Functional Class III
    or IV) in those patients who remain symptomatic
    despite stable, optimal medical therapy and have
    a left ventricular ejection fraction less than or
    equal to 35 and a QRS duration of 130 ms.
  • Contraindications
  • Medtronic ICDs and CRT-ICDs are contraindicated
    in patients whose ventricular tachyarrhythmias
    may have transient or reversible causes, patients
    with incessant VT or VF, patients who have a
    unipolar pacemaker. Medtronic ICDs are also
    contraindicated for patients whose primary
    disorder is bradyarrhythmia.
  • Warnings and Precautions
  • Changes in a patients disease and/or
    medications may alter the efficacy of the
    devices programmed parameters. Patients should
    avoid sources of magnetic and electromagnetic
    radiation to avoid possible underdetection,
    inappropriate sensing and/or therapy delivery,
    tissue damage, induction of an arrhythmia, device
    electrical reset or device damage. Do not place
    transthoracic defibrillation paddles directly
    over the device. Additionally, for CRT-ICDs,
    certain programming and device operations may not
    provide cardiac resynchronization.
  • Potential Complications
  • Potential complications include, but are not
    limited to, rejection phenomena, erosion through
    the skin, muscle or nerve stimulation,
    oversensing, failure to detect and/or terminate
    tachyarrhythmia episodes, acceleration of
    ventricular tachycardia, and surgical
    complications such as hematoma, infection,
    inflammation, and thrombosis.
  • See the device manual for detailed information
    regarding the implant procedure, indications,
    contraindications, warnings, precautions, and
    potential complications/adverse events. For
    further information, please call Medtronic at
    1-800-328-2518 and/or consult Medtronics website
    at www.medtronic.com.
  • Caution Federal law (USA) restricts these
    devices to sale by or on the order of a
    physician.

8
  • Brief Statement 2090 Programmer
  • The Medtronic/Vitatron CareLink programmer
    system is comprised of prescription devices
    indicated for use in the interrogation and
    programming of implantable medical devices.
    Prior to use, refer to the Programmer Reference
    Guide as well as the appropriate programmer
    software and implantable device technical manuals
    for more information related to specific
    implantable device models. Programming should be
    attempted only by appropriately trained personnel
    after careful study of the technical manual for
    the implantable device and after careful
    determination of appropriate parameter values
    based on the patient's condition and pacing
    system used. The Medtronic/Vitatron CareLink
    programmer must be used only for programming
    implantable devices manufactured by Medtronic or
    Vitatron.
  • See the device manual for detailed information
    regarding the instructions for use, indications,
    contraindications, warnings, precautions, and
    potential adverse events. For further
    information, please call Medtronic at
    1-800-328-2518 and/or consult Medtronics website
    at www.medtronic.com.
  • Caution Federal law (USA) restricts this
    device to sale by or on the order of a physician.

www.medtronic.com Medtronic USA, Inc. Toll-free
1 (800) 328-2518 (24-hour technical support
for physicians and medical professionals) April
2006
Write a Comment
User Comments (0)
About PowerShow.com